A previous study reported that IL-6 has a favorable prognostic effect on cerebral ischemia and dermatological diseases because it inhibits the production of tumor necrosis factor-α and IL-1, which are classical proinflammatory cytokines [24]. This evidence concerns the gene IL6 and brain ischemia.